NCT00462748
A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)
See it on ClinicalTrials.gov ↗786 people
33.5%
66.5%
263 womenmiddle line = equal numbers523 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-06
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 64.3 years
- Age 65+
- 27.9%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 98.2% · Black / African American 0.8% · Asian 0.6% · Other 0.4%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Patient Is Pregnant, Lactating, Or A Female Patient Of Childbearing Potential Not Using Adequate Contraception”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Patient Is Pregnant, Lactating, Or A Female Patient Of Childbearing Potential Not Using Adequate Contraception”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Patient Is Pregnant, Lactating, Or A Female Patient Of Childbearing Potential Not Using Adequate Contraception”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Patient Has A History Of, Or Active Liver Disease (Persistent Elevation Of Alt / Ast (\>3xuln)”
- No seizures
Women with epilepsy or past seizures were turned away.
“…Suggestive Of Myopathy Or Predisposing To The Development Of Renal Failure Secondary To Rhabdomyolysis (E.G. Sepsis, Hypotension, Major Surgery, Trauma, Severe Metabolic, Severe Endocrine And Electrolyte Disorders Or Uncontrolled Seizures)”
Study titles and rules are shown in their original English.